Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema
Shaw, Lincoln T, Mackin, Anna, Shah, Reanna, Jain, Siona, Jain, Prisha, Nayak, Ravi, Hariprasad, Seenu M
Published in Expert opinion on investigational drugs (02.06.2020)
Published in Expert opinion on investigational drugs (02.06.2020)
Get more information
Journal Article